Published in Hum Mol Genet on October 03, 2014
Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med (2015) 0.86
Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Hum Mol Genet (2016) 0.76
Self-cytoplasmic DNA upregulates the mutator enzyme APOBEC3A leading to chromosomal DNA damage. Nucleic Acids Res (2017) 0.75
Prostate stem cell antigen variation rs2294008 associated with the risk of bladder cancer. Int J Clin Exp Med (2015) 0.75
Re-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells. Oncotarget (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
A map of human genome variation from population-scale sequencing. Nature (2010) 121.13
Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 115.71
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (2007) 43.16
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ (1987) 27.11
Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet (2012) 11.29
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet (2005) 5.01
Cytochrome p450 and chemical toxicology. Chem Res Toxicol (2007) 4.49
Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet (2010) 4.36
Association between smoking and risk of bladder cancer among men and women. JAMA (2011) 4.31
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci U S A (2006) 3.76
Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst (2001) 3.05
Arsenic and cancers. Lancet (1988) 2.93
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet (2009) 2.76
Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res (2002) 2.62
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene (2000) 2.61
Environmental and chemical carcinogenesis. Semin Cancer Biol (2004) 2.50
European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet (2011) 1.58
Occupation and bladder cancer among men in Western Europe. Cancer Causes Control (2003) 1.54
Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev (2007) 1.52
Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem (1999) 1.50
CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Res (1994) 1.49
Familial aggregation of urothelial cell carcinoma. Int J Cancer (2002) 1.43
A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nat Genet (2012) 1.37
A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet (2011) 1.36
Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci U S A (2012) 1.36
Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet (2013) 1.34
Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol Biomarkers Prev (1994) 1.30
Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet (1995) 1.30
Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses. Mutat Res (1997) 1.24
Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn J Cancer Res (1999) 1.13
Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev (1995) 1.08
Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in cigarette smoke condensate. Carcinogenesis (1991) 1.06
Occupation and bladder cancer risk in a population-based case-control study in New Hampshire. Cancer Causes Control (2004) 1.06
Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population. Carcinogenesis (2009) 1.03
Genetic score of multiple risk-associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer. Genes Chromosomes Cancer (2013) 0.98
Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity. Toxicol Lett (1994) 0.95
Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer. Int J Cancer (2014) 0.85
Polycyclic aromatic hydrocarbon (PAH) metabolizing enzyme activities in human lung, and their inducibility by exposure to naphthalene, phenanthrene, pyrene, chrysene, and benzo(a)pyrene as shown in the rat lung and liver. Arch Toxicol (2006) 0.82
Environmental exposure, chlorinated drinking water, and bladder cancer. World J Urol (2003) 0.80
Retracted CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: a meta-analysis. Tumour Biol (2013) 0.78
Meta-analysis of the CYP1A2 -163C>A polymorphism and lung cancer risk. Asian Pac J Cancer Prev (2013) 0.77
Current evidence on the relationship between three polymorphisms in the CYP1A2 gene and the risk of cancer. Eur J Cancer Prev (2013) 0.77
Role of CYP1A2 1F polymorphism in cancer risk: evidence from a meta-analysis of 46 case-control studies. Gene (2013) 0.77
Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk. Nat Genet (2014) 1.49
MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer. Int J Urol (2015) 1.46
A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nat Genet (2012) 1.37
The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster. PLoS One (2014) 1.35
Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: a phase II study in Japanese patients with cytokine-refractory metastatic renal cell Carcinoma. Eur J Cancer (2011) 1.26
The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer. J Hum Genet (2013) 1.25
Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1. Nat Genet (2014) 1.23
The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer. Oncotarget (2014) 1.16
Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer. FEBS Lett (2014) 1.07
Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer. Int J Oncol (2014) 1.07
Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer. Cancer Sci (2015) 1.04
Construction of a population-specific HLA imputation reference panel and its application to Graves' disease risk in Japanese. Nat Genet (2015) 1.02
Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer. FEBS Lett (2014) 1.02
MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker. Br J Cancer (2015) 1.01
MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer. Int J Oncol (2015) 0.97
Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C. J Hum Genet (2014) 0.97
Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness. Oncotarget (2016) 0.95
Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma. J Urol (2014) 0.92
Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer. PLoS One (2014) 0.91
CLCA2 as a p53-inducible senescence mediator. Neoplasia (2012) 0.89
Clinical experience with once-daily tacrolimus in de novo kidney transplant recipients from living donors in Japan: 1-year follow up. Cent European J Urol (2013) 0.88
Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma. Int J Oncol (2014) 0.87
Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423. PLoS One (2014) 0.86
A paracrine mechanism involving renal tubular cells, adipocytes and macrophages promotes kidney stone formation in a simulated metabolic syndrome environment. J Urol (2014) 0.85
Genome wide association study of age at menarche in the Japanese population. PLoS One (2013) 0.85
Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma. J Hum Genet (2015) 0.82
Trans-ethnic meta-analysis of white blood cell phenotypes. Hum Mol Genet (2014) 0.82
Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer. Cancer Sci (2016) 0.81
The role of microRNAs in bladder cancer. Investig Clin Urol (2016) 0.79
Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases. J Infect Chemother (2015) 0.79
Feasibility of Neoadjuvant Ad-REIC Gene Therapy in Patients with High-Risk Localized Prostate Cancer Undergoing Radical Prostatectomy. Clin Transl Sci (2015) 0.79
Regulation of iron homeostasis by the p53-ISCU pathway. Sci Rep (2015) 0.79
Adjustment of Cell-Type Composition Minimizes Systematic Bias in Blood DNA Methylation Profiles Derived by DNA Collection Protocols. PLoS One (2016) 0.79
The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013. J Infect Chemother (2015) 0.78
Impact of PSCA variation on gastric ulcer susceptibility. PLoS One (2013) 0.78
Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma. Oncol Rep (2014) 0.78
Novel susceptibility loci for hepatocellular carcinoma in chronic HBV carriers. Hepatobiliary Surg Nutr (2012) 0.78
Male non-gonococcal urethritis: From microbiological etiologies to demographic and clinical features. Int J Urol (2016) 0.77
Late Cornified Envelope Group I, a novel target of p53, regulates PRMT5 activity. Neoplasia (2014) 0.77
Regulation of myo-inositol biosynthesis by p53-ISYNA1 pathway. Int J Oncol (2016) 0.77
The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer. Int J Oncol (2015) 0.77
Nephrolithotomy performed concurrently with laparoendoscopic single-site pyeloplasty. Urology (2013) 0.76
Expression of ABCB6 is related to resistance to 5-FU, SN-38 and vincristine. Anticancer Res (2014) 0.76
Efficacy of tegafur-uracil in advanced urothelial cancer patients after the treatment failure of platinum-based chemotherapy. Anticancer Res (2015) 0.76
Synergistic anti-pancreatic cancer immunological effects by treatment with reduced expression in immortalized cells/dickkopf-3 protein and peripheral blood mononuclear cells. J Gastroenterol Hepatol (2016) 0.76
EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis. Neoplasia (2017) 0.75
Efficacy of Everolimus for Treating Renal Angiomyolipoma with Inferior Vena Cava Thrombus Associated with Tuberous Sclerosis: A Case Report. Urol Case Rep (2017) 0.75
A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy. Sci Rep (2016) 0.75
Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan. J Infect Chemother (2016) 0.75
Effect of a Bicyclic Pyrimidine Derivative (KRP-103), a Novel Selective Tachykinin NK1 Receptor Antagonist, on Bladder Function in Guinea Pigs. Drug Res (Stuttg) (2017) 0.75
Comparison of short-term and long-term neoadjuvant hormone therapy prior to radical prostatectomy: a systematic review and meta-analysis. Scand J Urol (2022) 0.75
Antimicrobial stewardship in urology. Int J Urol (2014) 0.75
Postoperative infectious complications in patients undergoing holmium laser enucleation of the prostate: Risk factors and microbiological analysis. Int J Urol (2016) 0.75
Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial. J Antimicrob Chemother (2016) 0.75
Overall survival of 1st-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study. Cancer Sci (2017) 0.75
Successful microscopic renal autotransplantation for left renal aneurysm associated with segmental arterial mediolysis. J Vasc Surg (2016) 0.75
Regulation of tubular recycling endosome biogenesis by the p53-MICALL1 pathway. Int J Oncol (2017) 0.75
Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer. Urol Oncol (2019) 0.75
Identification of a novel p53 target, COL17A1, that inhibits breast cancer cell migration and invasion. Oncotarget (2017) 0.75
The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: A systematic review. Urol Oncol (2019) 0.75
Identification of a novel p53 target, COL17A1, that inhibits breast cancer cell migration and invasion. Oncotarget (2017) 0.75
The Prostate in Female? Clear Cell Adenocarcinoma in a Female Urethral Diverticulum. Urology (2016) 0.75
A comparison of cooling methods for laparoscopic partial nephrectomy. Urology (2008) 0.75
Reality of nerve sparing and surgical margins in surgeons' early experience with robot-assisted radical prostatectomy in Japan. Int J Urol (2017) 0.75